<?xml version='1.0' encoding='UTF-8'?><?xml-stylesheet href="http://www.blogger.com/styles/atom.css" type="text/css"?><feed xmlns='http://www.w3.org/2005/Atom' xmlns:openSearch='http://a9.com/-/spec/opensearchrss/1.0/' xmlns:georss='http://www.georss.org/georss' xmlns:gd='http://schemas.google.com/g/2005' xmlns:thr='http://purl.org/syndication/thread/1.0'><id>tag:blogger.com,1999:blog-19395888</id><updated>2011-04-21T13:47:42.382-07:00</updated><title type='text'>Externship Projects</title><subtitle type='html'></subtitle><link rel='http://schemas.google.com/g/2005#feed' type='application/atom+xml' href='http://pharmdexternship.blogspot.com/feeds/posts/default'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/19395888/posts/default?max-results=100'/><link rel='alternate' type='text/html' href='http://pharmdexternship.blogspot.com/'/><link rel='hub' href='http://pubsubhubbub.appspot.com/'/><author><name>Martha</name><uri>http://www.blogger.com/profile/01620193938827479407</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><generator version='7.00' uri='http://www.blogger.com'>Blogger</generator><openSearch:totalResults>5</openSearch:totalResults><openSearch:startIndex>1</openSearch:startIndex><openSearch:itemsPerPage>100</openSearch:itemsPerPage><entry><id>tag:blogger.com,1999:blog-19395888.post-115853106349298224</id><published>2006-09-17T14:36:00.000-07:00</published><updated>2006-09-17T15:11:03.630-07:00</updated><title type='text'>To look up</title><content type='html'>Strange things that I have seen doctors do that I'd like to look up:&lt;br /&gt;gabapentin prn&lt;br /&gt;super high  erythromycin dose by dermatologist&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/19395888-115853106349298224?l=pharmdexternship.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmdexternship.blogspot.com/feeds/115853106349298224/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=19395888&amp;postID=115853106349298224' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/19395888/posts/default/115853106349298224'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/19395888/posts/default/115853106349298224'/><link rel='alternate' type='text/html' href='http://pharmdexternship.blogspot.com/2006/09/to-look-up.html' title='To look up'/><author><name>Martha</name><uri>http://www.blogger.com/profile/01620193938827479407</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-19395888.post-115838623488698075</id><published>2006-09-15T22:30:00.000-07:00</published><updated>2006-09-15T22:57:16.856-07:00</updated><title type='text'>Clozapine registries</title><content type='html'>This is a comprehensive list of the companies marketing clozapine as of September 2006:&lt;br /&gt;&lt;br /&gt;Novartis has brand name Clozaril registry at &lt;a href="http://www.clozaril.com/index.jsp"&gt;www.clozaril.com&lt;/a&gt;&lt;br /&gt;Par has &lt;a href="https://www.parclozapine.com/forms/public_l2.jsp?action=phys"&gt;www.parclozapine.com&lt;/a&gt;&lt;br /&gt;Mylan has CPAS at &lt;a href="http://www.mylan-clozapine.com/"&gt;www.mylan-clozapine.com&lt;/a&gt;&lt;br /&gt;Ivax  has &lt;a href="http://www.clozapineregistry.com/pages/index.jsp"&gt;www.clozapine-registry.com&lt;/a&gt; (previously marketed by Zenith-Goldline Pharmaceuticals)&lt;br /&gt;Caraco is at &lt;a href="https://www.caracoclozapine.com/ASPX/index.aspx"&gt;www.caracoclozapine.com&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;FazaClo is the ODT version &lt;a href="http://www.clozapineregistry.com/pages/index.jsp"&gt;www.fazaclo.com&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;Data from FDA Orange Book and Google Searches (gotta love them)&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/19395888-115838623488698075?l=pharmdexternship.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmdexternship.blogspot.com/feeds/115838623488698075/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=19395888&amp;postID=115838623488698075' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/19395888/posts/default/115838623488698075'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/19395888/posts/default/115838623488698075'/><link rel='alternate' type='text/html' href='http://pharmdexternship.blogspot.com/2006/09/clozapine-registries.html' title='Clozapine registries'/><author><name>Martha</name><uri>http://www.blogger.com/profile/01620193938827479407</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-19395888.post-113441194857174219</id><published>2005-12-12T10:23:00.000-08:00</published><updated>2005-12-12T10:25:48.583-08:00</updated><title type='text'>Article on Plan B</title><content type='html'>From "60 Minutes", an &lt;a href="http://www.cbsnews.com/stories/2005/11/22/60minutes/main1068924.shtml"&gt;article on Plan B&lt;/a&gt;.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/19395888-113441194857174219?l=pharmdexternship.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmdexternship.blogspot.com/feeds/113441194857174219/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=19395888&amp;postID=113441194857174219' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/19395888/posts/default/113441194857174219'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/19395888/posts/default/113441194857174219'/><link rel='alternate' type='text/html' href='http://pharmdexternship.blogspot.com/2005/12/article-on-plan-b.html' title='Article on Plan B'/><author><name>Martha</name><uri>http://www.blogger.com/profile/01620193938827479407</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-19395888.post-113390498199532055</id><published>2005-12-06T12:57:00.000-08:00</published><updated>2005-12-08T11:45:08.690-08:00</updated><title type='text'>Opioid Dose Conversions-focus on methadone</title><content type='html'>Resources:&lt;br /&gt;&lt;br /&gt;Global RPh- has an automated &lt;a href="http://globalrph.com/narcoticonv.htm"&gt;narcotic conversion &lt;/a&gt;calculator. The only tricky part is the "Reduction for incomplete cross tolerance" field. This is a calculation that takes into consideration the concept of starting with a less than equianalgesic dose to avoid overdosing the patient. Many clinicians start with a 25-50% dose reduction.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.aafp.org/afp/20050401/1353.html"&gt;American Family Physician article&lt;/a&gt; on using methadone for chronic pain treatment. A concise article with easy-to-use dosing tables.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.ohsu.edu/ahec/pain/part2sect3.pdf"&gt;OHSU opioid management &lt;/a&gt;document-has some dose conversion charts, but is harder to use. This does not include information on methadone dosing.&lt;br /&gt;&lt;br /&gt;DOSE CONVERSIONS:&lt;br /&gt;CAUTION: methadone conversions are non-linear. Again, the American Family Physician article gives a good example of this. (One way to think of this non-linear pattern is to think that morphine and other opioids "top out" more easily than methadone, while methadone keeps its potency at very high doses.)&lt;br /&gt;&lt;br /&gt;Morphine:Methadone conversion ratio for-&lt;br /&gt;under 100 mg morphine 3:1 , or, 33% of morphine dose&lt;br /&gt;100-300mg morphine 5:1 , or, 20% of morphine dose&lt;br /&gt;300-600 mg morphine 10:1 , or, 10% of morphine dose&lt;br /&gt;600-800 mg morphine 12:1 , or, 8.3% of morphine dose&lt;br /&gt;800-1000 mg morphine 15:1 , or, 6.7% of morphine dose&lt;br /&gt;over 1000 mg morphine 20:1 , or, 5% of morphine dose.&lt;br /&gt;&lt;br /&gt;Equianalgesic doses of other opioids:&lt;br /&gt;30 mg morphine = 30 mg hydrocodone = 7.5 mg hydromorphone = 20 mg oxycodone&lt;br /&gt;&lt;br /&gt;TO CALCULATE: add up the total daily dose of opioid, convert it to morphine equivalents, and multiply it by the % in the table above. Reduce this about 25% to get a starting dose. Divide this into 3 daily doses, to be taken every 8 hours.&lt;br /&gt;&lt;br /&gt;EXAMPLE #1: Conversion of Vicodin to methadone: Your patient is taking 2 vicodin (5/500) four times daily for a total of 40 mg hydrocodone per 24 hours.&lt;br /&gt;The equianalgesic dose of methadone is 13.2 mg (=40 x 0.33). You decide to start at about 75% of that dose, or 10 mg methadone/24 hours.&lt;br /&gt;The usual starting dose schedule is q 8 hours, and methadone comes as 5 mg, 10 mg, and 40 mg tablets. 10 mg is not conveniently divided among three doses.&lt;br /&gt;&lt;br /&gt;Your patient has the highest pain level in the late afternoon, so you decide to dose 2.5 mg q am (about 7 am for this patient), 5 mg at about 3 pm, and 2.5 mg q hs.&lt;br /&gt;You counsel the patient to not expect the full level of pain relief from methadone during the first week, and they may need vicodin for breakthrough pain during this time. You schedule a follow-up in 1 week.&lt;br /&gt;&lt;br /&gt;TO MONITOR: Pain levels (pain diary can help), sedation, constipation.&lt;br /&gt;&lt;br /&gt;Methadone drug interactions:&lt;br /&gt;Partial opiate agonists: these knock the methadone off of the receptors and can precipitate withdrawl symptoms.&lt;br /&gt;CYP 3A4 inhibitors can increase the systemic methadone levels.&lt;br /&gt;&lt;br /&gt;Documented drug interactions (not a comprehensive list):&lt;br /&gt;Increase methadone effects: ciprofloxacin, diazepam, ethanol, fluconazole, urinary alkalinizers.&lt;br /&gt;Decrease methadone effects: phenobarbital, phenytoin, rifampin, many anti-HIV drugs, and urinary acidifiers.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/19395888-113390498199532055?l=pharmdexternship.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmdexternship.blogspot.com/feeds/113390498199532055/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=19395888&amp;postID=113390498199532055' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/19395888/posts/default/113390498199532055'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/19395888/posts/default/113390498199532055'/><link rel='alternate' type='text/html' href='http://pharmdexternship.blogspot.com/2005/12/opioid-dose-conversions-focus-on.html' title='Opioid Dose Conversions-focus on methadone'/><author><name>Martha</name><uri>http://www.blogger.com/profile/01620193938827479407</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-19395888.post-113321129276254983</id><published>2005-11-28T12:33:00.000-08:00</published><updated>2005-11-28T12:57:32.600-08:00</updated><title type='text'>Resources/Guidelines</title><content type='html'>&lt;p class="MsoNormal"&gt;From 2001  (Ann Internal Med) and U Michigan Guidelines&lt;o:p&gt;&lt;/o:p&gt;&lt;/p&gt;             &lt;p class="MsoNormal"&gt;SORE THROAT:&lt;br /&gt;Guidelines &lt;a href="http://www.annals.org/cgi/reprint/134/6/506.pdf"&gt;Ann Internal Med&lt;/a&gt;, &lt;a href="http://cme.med.umich.edu/pdf/guideline/phrngts.pdf"&gt;U Michigan&lt;/a&gt;&lt;br /&gt;All adult patients with pharyngitis should be clinically screened for the presence of the Centor criteria:&lt;br /&gt;-tonsillar      exudates,&lt;br /&gt;-tender      anterior cervical lymphadenopathy,&lt;br /&gt;-absence      of cough&lt;br /&gt;-history      of fever.&lt;br /&gt;Yes to 3 or 4 criteria: 40 to 60 percent chance of strep throat.&lt;br /&gt;No to 3 or 4 criteria: only 20 percent chance.&lt;br /&gt;Patients with none or one of these criteria should not be tested or treated. &lt;/p&gt;   &lt;p class="MsoNormal" style=""&gt;All patients with pharyngitis should be offered appropriate doses of analgesics, antipyretics and other supportive care. &lt;/p&gt;   &lt;p class="MsoNormal"&gt;The preferred antimicrobial agent for treatment of acute pharyngitis is penicillin, or erythromycin for penicillin-allergic patients. There is no evidence of group A beta-hemolytic streptococcus resistance to or tolerance of penicillin, and erythromycin resistance rates are low in the &lt;st1:country-region&gt;&lt;st1:place&gt;United   States&lt;/st1:place&gt;&lt;/st1:country-region&gt;. &lt;/p&gt;         &lt;p class="MsoNormal"&gt;Treatment: Penicillin 250 mg tid-qid&lt;span style=""&gt;  &lt;/span&gt;or 500 mg bid for 10 days&lt;br /&gt;Alternative: Erythromycin base 333 tid for 10 days&lt;br /&gt;Other alternative: First-gen cephalosporin&lt;/p&gt;     &lt;p class="MsoNormal"&gt;These guidelines do not apply to patients with a history of rheumatic fever, valvular heart disease, immunosuppression, recurrent or chronic pharyngitis, or to patients with sore throats not caused by acute pharyngitis. &lt;b style=""&gt;Also, the guidelines should not be used during a known epidemic of &lt;/b&gt;acute rheumatic fever or&lt;b style=""&gt; streptococcal pharyngitis&lt;/b&gt; or in nonindustrialized countries in which the endemic rate of acute rheumatic fever is much higher than in the &lt;st1:country-region&gt;&lt;st1:place&gt;United States&lt;/st1:place&gt;&lt;/st1:country-region&gt;.&lt;o:p&gt;&lt;/o:p&gt;&lt;/p&gt;     &lt;p class="MsoNormal"&gt;The goal of treatment of strep throat is prevention of rheumatic heart disease.&lt;br /&gt;&lt;o:p&gt; &lt;/o:p&gt;&lt;/p&gt;     &lt;p class="MsoNormal"&gt;SINUS PAIN:&lt;br /&gt;&lt;a href="http://www.annals.org/cgi/reprint/134/6/498.pdf"&gt;Guidelines&lt;/a&gt;&lt;br /&gt;Sinusitis: Less than 7 days is usually viral (&gt;90%). Not recommended to start antibiotics unless symptoms have been present more than 7 days. Amoxicillin still preferred. &lt;o:p&gt;&lt;/o:p&gt;&lt;/p&gt;       &lt;p class="MsoNormal"&gt;COUGH:&lt;br /&gt;&lt;a href="http://www.annals.org/cgi/reprint/134/6/521.pdf"&gt;Guidelines&lt;/a&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;br /&gt;Bronchitis: Purulent sputum not indicative of bacterial infection&lt;o:p&gt;&lt;/o:p&gt;&lt;/p&gt;   &lt;p class="MsoNormal"&gt;More likely to be pneumonia if heart rate &gt;100, resp &gt;24, and temp &gt;38 C. &lt;o:p&gt;&lt;/o:p&gt;&lt;/p&gt;   &lt;p class="MsoNormal"&gt;90% of acute uncomplicated bronchitis cases are non-bacterial&lt;/p&gt;   &lt;p class="MsoNormal"&gt;&lt;u&gt;Albuterol recommended to shorten duration of cough&lt;o:p&gt;&lt;/o:p&gt;&lt;/u&gt;&lt;/p&gt;   &lt;p class="MsoNormal"&gt;-At 7 days, 40-60% of albuterol treated patients were still coughing, versus 90% of control. &lt;/p&gt;   &lt;p class="MsoNormal"&gt;-Better than antibiotics in studies!&lt;br /&gt;To get the abstracts, go to &lt;a href="http://www.pubmed.gov/"&gt;www.pubmed.gov&lt;/a&gt; and type in 1940815 , or 7864949&lt;/p&gt; &lt;p class="MsoNormal"&gt;GENERAL UPPER RESPIRATORY TRACT INFECTION&lt;br /&gt;&lt;a href="http://www.annals.org/cgi/reprint/134/6/487.pdf"&gt;Guidelines&lt;/a&gt;&lt;br /&gt;&lt;/p&gt; &lt;p class="MsoNormal"&gt;Almost never bacterial.&lt;br /&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/19395888-113321129276254983?l=pharmdexternship.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://pharmdexternship.blogspot.com/feeds/113321129276254983/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=19395888&amp;postID=113321129276254983' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/19395888/posts/default/113321129276254983'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/19395888/posts/default/113321129276254983'/><link rel='alternate' type='text/html' href='http://pharmdexternship.blogspot.com/2005/11/resourcesguidelines.html' title='Resources/Guidelines'/><author><name>Martha</name><uri>http://www.blogger.com/profile/01620193938827479407</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry></feed>
